Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GPR109B |
| Upstream (Parents) |
|---|
| (<<) ARSD → GPR109B |
| (<<) BCL2A1 → GPR109B |
| (<<) BCL6 → GPR109B |
| (<<) CASP10 → GPR109B |
| (<<) CCND1 → GPR109B |
| (<<) CHST11 → GPR109B |
| (<<) MAFF → GPR109B |
| (<<) MMP1 → GPR109B |
| (<<) PDPK1 → GPR109B |
| (<<) RAC2 → GPR109B |
| (<<) RND3 → GPR109B |
| (<<) STAT4 → GPR109B |
| (<<) WNT5A → GPR109B |
| Downstream (Children) |
|---|
| GPR109B → CAPRIN2 (>>) |
| GPR109B → CRNN (>>) |
| GPR109B → FAM48A (>>) |
| GPR109B → IL1B (>>) |
| GPR109B → IL1R2 (>>) |
| GPR109B → KHDRBS3 (>>) |
| GPR109B → MERTK (>>) |
| GPR109B → MYO1E (>>) |
| GPR109B → NRN1 (>>) |
| GPR109B → SOD2 (>>) |
